Ronald Passeri
Internal Medicine · Salisbury, MDNPI 1871582049
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.8% of the total across 277 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 277 payments — averaging $23.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$1K
- Amgen$958
- Boehringer Ingelheim$612
- Lilly USA, LLC$588
- AbbVie$409
- plus $2K from 18 others
What the payments were for
- Speaking & faculty fees$3806%
- Food & beverage$6,15593%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 70 | $1,390 |
| AstraZeneca | 42 | $1,115 |
| Amgen | 25 | $958 |
| Boehringer Ingelheim | 37 | $612 |
| Lilly USA, LLC | 31 | $588 |
| AbbVie(2 entities) | 18 | $409 |
| Sanofi-aventis U.S. LLC | 7 | $406 |
| Astellas Pharma US Inc | 12 | $270 |
| Pfizer | 14 | $180 |
| GSK | 3 | $155 |
| Medtronic | 1 | $148 |
| Johnson & Johnson | 1 | $83 |
| Sanofi | 1 | $60 |
| Mylan Specialty L.p. | 3 | $57 |
| Amarin Pharma, Inc. | 3 | $52 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Abbott | 1 | $15 |
| Merck | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,634 in reported general payments places this provider in the 90th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Salisbury
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Brian HarveyAnnapolis$220K
- Jeremy SugarmanBaltimore$210K
- Florence HounPotomac$161K
- Matthew MintzBethesda$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.